Biomerica, Inc.
BMRA
$2.27
-$0.08-3.21%
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.45M | 4.33M | 4.46M | 4.88M | 5.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.45M | 4.33M | 4.46M | 4.88M | 5.31M |
| Cost of Revenue | 4.09M | 4.14M | 4.21M | 4.25M | 4.81M |
| Gross Profit | 360.00K | 187.00K | 250.00K | 636.00K | 501.00K |
| SG&A Expenses | 4.89M | 4.71M | 4.64M | 4.58M | 4.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.77M | 9.68M | 9.72M | 9.77M | 10.45M |
| Operating Income | -5.32M | -5.35M | -5.27M | -4.89M | -5.14M |
| Income Before Tax | -3.75M | -4.15M | -4.02M | -3.65M | -4.97M |
| Income Tax Expenses | 22.00K | 21.00K | 9.00K | 1.00K | 2.00K |
| Earnings from Continuing Operations | -3.78 | -4.17 | -4.03 | -3.66 | -4.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.78M | -4.17M | -4.03M | -3.66M | -4.97M |
| EBIT | -5.32M | -5.35M | -5.27M | -4.89M | -5.14M |
| EBITDA | -5.25M | -5.27M | -5.18M | -4.80M | -5.05M |
| EPS Basic | -1.26 | -1.59 | -1.64 | -1.63 | -2.25 |
| Normalized Basic EPS | -1.07 | -0.99 | -1.02 | -1.02 | -1.41 |
| EPS Diluted | -1.27 | -1.59 | -1.64 | -1.63 | -2.26 |
| Normalized Diluted EPS | -1.07 | -0.99 | -1.02 | -1.02 | -1.41 |
| Average Basic Shares Outstanding | 11.66M | 10.76M | 10.15M | 9.38M | 8.85M |
| Average Diluted Shares Outstanding | 11.66M | 10.76M | 10.15M | 9.38M | 8.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |